|Name of Trial
|A single and repeat dosing study to characterize the safety and tolerability of R-3750 orally delivered to patients with mild to moderate Ulcerative Colitis (UC).
|Researchers in the BOOM-IBD Clinical Trial are studying whether nerve stimulation can be effective in treating patients with Crohn's disease and ulcerative colitis.
|DUET Study (UC or CD)
|A study to evaluate the efficacy and safety of Guselkumab and Golimumab for patients with moderately to severe active Ulcerative Colitis of Crohn's Disease.
|A study to determine whether AVB-114, a mesenchymal cell substrate system implanted in perianal fistula tract, compared to standard of care treatment is effective in inducing remission of the treated complex perianal fistula in subjects with Crohn’s Disease (CD).
Please contact Gianna Morales for more information: